LeserbriefKommentar
Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients
JAMA · 2024
DOI: 10.1001/jama.2024.6839 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Inez Schoenmakers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, United Kingdom. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Denosumab, Hypocalcemia, Kidney Failure, Chronic. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Bone Density Conservation AgentsDenosumabHypocalcemiaKidney Failure, ChronicRenal DialysisAgedFemaleHumansMaleMiddle AgedCalcium
Substanzen
Bone Density Conservation AgentsCalciumDenosumab
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, United Kingdom.
Zitieren
APA
Schoenmakers, I., & Fraser, W. D. (2024). Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients. JAMA. https://doi.org/10.1001/jama.2024.6839
Vancouver
Schoenmakers I, Fraser WD. Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients. JAMA. 2024. doi:10.1001/jama.2024.6839
BibTeX
@article{Schoenmakers2024,
author = {Schoenmakers, Inez and Fraser, William D},
title = {Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.6839}
}
EUVIMED